BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 135489)

  • 1. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
    Hayashi S
    Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
    Hayashi S
    Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonspecific resistance to tumor allograft.
    Rejthar A; Wotke J; Rejtharová A; Jasková J
    Neoplasma; 1975; 22(3):273-8. PubMed ID: 1099469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage processing of antigen for induction of tumor immunity.
    Brunda MJ; Raffel S
    Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the immune response of newborn and adult animals to the administration of tumor extracts].
    Nikonova MF; Maĭskiĭ IN; Pokrovskaia TA
    Biull Eksp Biol Med; 1975 Jun; 79(6):85-8. PubMed ID: 177126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologically mediated macrophage aggregation in monolayers of peritoneal cells from BCG-sensitized mice.
    Preston PM; Hart PD; Brown IN
    Immunology; 1977 Jan; 32(1):33-41. PubMed ID: 139359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
    Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
    Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction of tumor cells by BCG-activated alqolar macrophages.
    Zwilling BS; Campolito LB
    J Immunol; 1977 Sep; 119(3):838-41. PubMed ID: 330756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some immunologically based reactions that can cause the regression of large tumor masses.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
    Viadro MM
    Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
    Moriyama M; Miwa H; Moriya N; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.